introduction
XBiotech is developing therapies based on natural human immunity to interleukin-1⍺ (IL-1⍺), a substance produced by the body that can cause harmful inflammation.
Natural human immunity is what protects us against infectious disease—it is the difference between life and death.
Clinical
At XBiotech, we are pioneering advancements in healthcare through rigorous clinical trials. These trials play a vital role in evaluating our pipeline of investigational therapies across various therapeutic areas, guided by stringent regulatory standards like the FDA and EMA. Each trial represents a collaborative effort to bring new treatments to patients, aiming to improve outcomes and quality of life worldwide. Visit our clinical trials portal to learn more about our ongoing research initiatives and the potential impact of our investigational therapies.
Modern medicine should help patients feel better, not worse. At XBiotech, we believe in the Hippocratic principle of "do no harm." We believe this is inherent to the innovative True Human™ antibody medicines we are developing. True Human™ antibodies move beyond the idea that effective medicines must come with toxicity or harmful side effects.
By utilizing the body’s natural immune system, XBiotech develops therapies that help you heal and feel better.